biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > 24-hour CEO

<< Previous

Bullboard Posts

Next >>

Comment by Aarcoron Dec 14, 2020 2:40pm

187 Views

Post# 32101504

RE:RE:24-hour CEO

Chrispi, given that presentations from the summer and fall indicated more deals were likely before end of calendar and that appears all but impossible at this late date, you seem to imply you have some undisclosed information when you say "we'll all be pleasantly surprised with her accomplishments soon enough". Can you explain ?

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec